Supply Chain Intelligence

Tenaya Therapeutics, Inc. Supply Chain

TNYA supply chain intelligence for Tenaya Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

TNYA ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
4Customers
3Debt Items
20Related Chains

Tenaya Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
RGNX REGENXBIO Inc. 72% Reciprocal relationship from RGNX graph: Reciprocal relationship from TNYA graph: Reciprocal relationship from RGNX graph: Reciprocal relationship from TNYA graph: Reciprocal relationship from RGNX g…
SNYNF Sanofi 72% . We may in the future pursue invalidity proceedings with respect to third-party patents. The outcome following legal assertions of invalidity is unpredictable. Even if resolved in our favor, these l…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from TNYA graph: . We may in the future pursue invalidity proceedings with respect to third-party patents. The outcome following lega…

Tenaya Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
ALNYLAM ALNYLAM 90% Pursuant to the terms of the Collaboration Agreement, Alnylam will pay the Company an upfront payment of up to $10.0 million within thirty (30) days after Alnylam’s receipt of an invoice from the Company.
RGNX REGENXBIO Inc. 72% Reciprocal relationship from RGNX graph: Reciprocal relationship from TNYA graph: Reciprocal relationship from RGNX graph: atent that will expire in 2034, one issued U.S. patent that will expire in 2…
SNYNF Sanofi 72% . We may in the future pursue invalidity proceedings with respect to third-party patents. The outcome following legal assertions of invalidity is unpredictable. Even if resolved in our favor, these l…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from TNYA graph: . We may in the future pursue invalidity proceedings with respect to third-party patents. The outcome following lega…

Tenaya Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
TNYA-DEBT Debt stack $10.1M 90% Market cache reports total debt of $10.1M.
TNYA-DEBT-13047 Warrants outstanding: 2289000 90% xbrl warrant detail from xbrl 2025-12-31.
TNYA-DEBT-13048 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.

Tenaya Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Tenaya Therapeutics, Inc..

Tenaya Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
TNYA-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 105 tracked holders.

Tenaya Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
View TNYA supply chain intel →

Explore the full interactive supply chain map for Tenaya Therapeutics, Inc..

Open TNYA supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map